Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysis.

Samuel J MinkoveJunfeng SunYan LiXizhong CuiDiane CooperPeter Q EichackerParizad Torabi-Parizi

Published in: Reviews in medical virology (2022)

Across studies with adjusted and unadjusted results, ICIs did not alter outcomes significantly. But studies with comprehensive adjusted outcome data controlling for confounding variables are necessary to determine whether ICIs impact COVID-19 outcomes in cancer patients.

Keyphrases

electronic health record
sars cov
big data
case control
papillary thyroid
type diabetes
machine learning
squamous cell carcinoma
adipose tissue
young adults
deep learning
skeletal muscle
lymph node metastasis
weight loss